Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Kritika Sarmah

Is Amgen Stock Outperforming the Nasdaq?

Headquartered in Thousand Oaks, California, Amgen Inc. (AMGN) is a renowned player in the biotechnology industry. Valued at $179.1 billion by market cap, the company has a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health & nephrology, and neuroscience markets.

Companies worth $10 billion or more are generally described as “large-cap stocks,” and AMGN fits right into that category. Amgen is a leader in the biopharmaceutical industry, advancing healthcare through innovative research and a strong portfolio that includes flagship drugs like Epogen, Aranesp, and Enbrel. Besides, the October 2023 acquisition of Horizon Therapeutics for $27.8 billion has enhanced its oncology portfolio with Kyprolis, furthering its commitment to innovative therapies.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.